Globus Medical (GMED) Receivables - Net (2016 - 2025)
Globus Medical's Receivables - Net history spans 15 years, with the latest figure at $678.9 million for Q4 2025.
- For Q4 2025, Receivables - Net rose 21.74% year-over-year to $678.9 million; the TTM value through Dec 2025 reached $678.9 million, up 21.74%, while the annual FY2025 figure was $678.9 million, 21.74% up from the prior year.
- Receivables - Net reached $678.9 million in Q4 2025 per GMED's latest filing, up from $619.1 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $678.9 million in Q4 2025 to a low of $159.6 million in Q3 2021.
- Average Receivables - Net over 5 years is $381.3 million, with a median of $367.1 million recorded in 2023.
- Peak YoY movement for Receivables - Net: soared 154.71% in 2024, then decreased 0.04% in 2025.
- A 5-year view of Receivables - Net shows it stood at $164.4 million in 2021, then grew by 29.68% to $213.2 million in 2022, then skyrocketed by 135.99% to $503.2 million in 2023, then increased by 10.82% to $557.7 million in 2024, then increased by 21.74% to $678.9 million in 2025.
- Per Business Quant, the three most recent readings for GMED's Receivables - Net are $678.9 million (Q4 2025), $619.1 million (Q3 2025), and $611.6 million (Q2 2025).